EGFR and prostate cancer: A correlation was also seen for the epithelial, but not blood vessel FAAH-IR with the local stage number, the immunoreactive score for phosphorylated epidermal growth factor receptor (pEGFR, a marker for prostate cancer outcome [37], Table 1), and with cytoplasmic, but not nuclear HER2 (human EGF receptor 2, data not shown).